A significant study on the safety of hydroxychloroquine as a treatment for COVID-19 has been retracted. So, what does this mean? What does it say about using the drug to treat COVID? What does it say about the way we do science?
Masthead
Editors in Chief
Austin Frakt
Aaron Carroll
Managing Editor
Adrianna McIntyre
Contributors
Kevin Outterson
Bill Gardner
Nicholas Bagley
Other ContributorsRecent posts
- What can we expect from re-opening HealthCare.gov? Hope.
- The Rising Crisis of Underinsurance: How the Biden Administration May Shape Inequities in Patient Affordability
- How Genomics Improve Cancer Survival and Patient Quality of Life: The Healthcare Triage Podcast
- The End of Surprise Billing for Medical Care?
- Drug Prices by Committee: One Way Biden Could Lower Costs
- Recent publications from Boston University’s Department of Health Law, Policy and Management: February 2021 Edition
- Out-of-network payments in Medicare Advantage
- Cancer Journal: What is health?
- Should You Worry About Covid Vaccine Side Effects?
- U.S. should prepare for a COVID-19 hospital consolidation surge
Archives
For speaking inquiries
Aaron’s stuff
Austin’s stuff
What’s Happening with Hydroxychloroquine?
06/18/2020
Tiffany Dohertyitem.php
Follow the blog
TIE Books
Amazon.com
Barnes & Noble
Indiebound
iBooks
Google
Kobo
Amazon.com
Barnes & Noble
Books-A-Million
iBooks
IndieBound
Powells
Buy at Amazon.com
Summary
Excerpt: Economic profit
Excerpt: Diminishing marginal utility
Excerpt: Four factors of production
Excerpt: Monopoly marginal revenue
Excerpt: Consumer/producer surplus
Amazon.com
Barnes & Noble
Books-A-Million
Borders
IndieBound
Powells
Borders
Barnes & Noble
IndieBound
Amazon.com
Books-A-Million
Powells
Austin and Aaron are participants in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to amazon.com.Tag cloud
ACA AcademyHealth access accountable care organizations Affordable Care Act announcement blogging cancer comic competitive bidding costs cost shifting COVID-19 employer-sponsored health insurance health care costs Healthcare Triage health insurance health insurance mandates health reform hospital readmissions hospitals individual mandate insurance exchange market power Massachusetts Medicaid Medicare Medicare Advantage mortality nutrition obesity On The Record physicians politics PPACA premiums prescription drugs quality reading list reflex RWJF spending uninsured Upshot vaccines
